Precipio, Inc. (PRPO) stock
PRPONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$19.17−0.79 (-3.96%)
Close on Nov 17, 2026Market cap $34.32MP/E –Yield –
Precipio EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Precipio's EPS for the twelve months ending Sep 30, 2024 was -$2.06. For fiscal 2025 it was -$0.23. The highest annual figure on record is -$0.23 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.23 | – |
| FY2024 | Dec 31, 2024 | -$2.93 | – |
| FY2023 | Dec 31, 2023 | -$4.51 | – |
| FY2022 | Dec 31, 2022 | -$10.73 | – |
| FY2021 | Dec 31, 2021 | -$8.00 | – |
| FY2020 | Dec 31, 2020 | -$17.00 | – |
| FY2019 | Dec 31, 2019 | -$46.60 | – |
| FY2018 | Dec 31, 2018 | -$276.40 | – |
| FY2017 | Dec 31, 2017 | -$2148.00 | – |
| FY2016 | Dec 31, 2016 | -$2832.00 | – |
| FY2015 | Dec 31, 2015 | -$42534.00 | – |
| FY2014 | Dec 31, 2014 | -$30753.00 | – |
| FY2013 | Dec 31, 2013 | -$35190.00 | – |
| FY2012 | Dec 31, 2012 | -$23715.00 | – |
| FY2011 | Dec 31, 2011 | -$40086.00 | – |
| FY2010 | Dec 31, 2010 | -$11016.00 | – |
| FY2009 | Dec 31, 2009 | -$7344.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.12 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.81 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.05 | – |
| Q2 FY2025 | Jun 30, 2025 | $0.05 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.59 | -190.8% |
| Q3 FY2024 | Sep 30, 2024 | -$0.42 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.83 | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.46 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.65 | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.04 | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.88 | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.61 | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.01 | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.79 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.80 | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.00 | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.94 | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.60 | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.80 | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.60 | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.20 | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.00 | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.60 | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.13 | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.20 | – |
| Q2 FY2019 | Jun 30, 2019 | -$21.00 | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.60 | – |
| Q4 FY2018 | Dec 31, 2018 | -$69.88 | – |
| Q3 FY2018 | Sep 30, 2018 | -$49.80 | – |
| Q2 FY2018 | Jun 30, 2018 | -$45.80 | – |
| Q1 FY2018 | Mar 31, 2018 | -$142.00 | – |
| Q3 FY2017 | Sep 30, 2017 | -$408.00 | – |
| Q2 FY2017 | Jun 30, 2017 | -$4605.00 | – |
| Q1 FY2017 | Mar 31, 2017 | -$507.00 | – |
| Q3 FY2016 | Sep 30, 2016 | -$345.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?